During the last session, CureVac N.V (NASDAQ:CVAC)’s traded shares were 0.62 million, with the beta value of the company hitting 2.43. At the end of the trading day, the stock’s price was $3.47, reflecting an intraday loss of -3.34% or -$0.12. The 52-week high for the CVAC share is $5.28, that puts it down -52.16 from that peak though still a striking 31.7% gain since the share price plummeted to a 52-week low of $2.37. The company’s market capitalization is $781.29M, and the average trade volume was 628.42K shares over the past three months.
CureVac N.V (CVAC) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.83. CVAC has a Sell rating from 0 analyst(s) out of 2 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 2 recommend a Buy rating for it.
CureVac N.V (NASDAQ:CVAC) trade information
CureVac N.V (CVAC) registered a -3.34% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -3.34% in intraday trading to $3.47, hitting a weekly high. The stock’s 5-day price performance is -2.53%, and it has moved by 16.44% in 30 days. Based on these gigs, the overall price performance for the year is 16.05%.
The consensus price target of analysts on Wall Street is $29, which implies an increase of 88.03% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $21 and $37 respectively. As a result, CVAC is trading at a discount of -966.28% off the target high and -505.19% off the low.
While earnings are projected to return -169.44% in 2025.
CVAC Dividends
CureVac N.V is due to release its next quarterly earnings in June. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
The next largest institutional holding, with 2.42 million shares, is of POINT72 ASSET MANAGEMENT, L.P.’s that is approximately 1.0801% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $8.24 million.
Also, the Mutual Funds coming in first place with the largest holdings of CureVac N.V (CVAC) shares are iShares Trust-iShares Core MSCI EAFE ETF and iShares Trust-iShares Biotechnology ETF . Data provided on Mar 31, 2025 indicates that iShares Trust-iShares Core MSCI EAFE ETF owns about 652.13 shares. This amounts to just over 0.29 percent of the company’s overall shares, with a $2.26 million market value. The same data shows that the other fund manager holds slightly less at 598.13, or about 0.27% of the stock, which is worth about $2.08 million.
